108 related articles for article (PubMed ID: 6259251)
1. Investigation of the usefulness of the plasma adenosine 3' 5' - cyclic monophosphate response to glucagon in thyroid disease.
Mac Neil S; Hendy GN; Amirrasooli H; Daggett PR; Tomlinson S
J Endocrinol Invest; 1980; 3(4):401-4. PubMed ID: 6259251
[TBL] [Abstract][Full Text] [Related]
2. Plasma cyclic AMP response to glucagon as an index of tissue responsiveness to thyroid hormone.
Paisey R; Elkeles RS; Hambley J; Belchetz PE
Diabete Metab; 1978 Dec; 4(4):267-70. PubMed ID: 215472
[TBL] [Abstract][Full Text] [Related]
3. Thyroid function and plasma cyclic AMP response to intravenous glucagon.
Madsen SN
Acta Endocrinol (Copenh); 1977 Aug; 85(4):760-8. PubMed ID: 196468
[TBL] [Abstract][Full Text] [Related]
4. [The effect of thyroid function on the increase of plasma cyclic AMP following glucagon injection (author's transl)].
Jäckel W; Heimes J; Herrmann J
J Clin Chem Clin Biochem; 1980 Dec; 18(12):909-15. PubMed ID: 6259272
[TBL] [Abstract][Full Text] [Related]
5. Plasma adenosine 3':5'-cyclic monophosphate response to glucagon in thyroid disease.
Elkeles RS; Lazarus JH; Siddle K; Campbell AK
Clin Sci Mol Med; 1975 Jan; 48(1):27-31. PubMed ID: 163165
[TBL] [Abstract][Full Text] [Related]
6. Effect of propranolol on the plasma cyclic AMP and cyclic GMP levels to massive doses of glucagon in euthyroid and hyperthyroid subjects.
Földes J; Gyertyánfy G; Piroska E; Juhász J
Acta Med Acad Sci Hung; 1977; 34(4):227-34. PubMed ID: 218419
[TBL] [Abstract][Full Text] [Related]
7. The effect of treatment of hyper- and hypothyroidism on urinary excretion of cyclic adenosine 3',5'-monophosphate.
Carter DJ; Heath DA
Acta Endocrinol (Copenh); 1977 Mar; 84(3):542-7. PubMed ID: 190841
[TBL] [Abstract][Full Text] [Related]
8. Propranolol versus carbimazole as the sole treatment for thyrotoxicosis. A consideration of circulating thyroid hormone levels and tissue thyroid function.
O'Malley BP; Abbott RJ; Barnett DB; Northover BJ; Rosenthal FD
Clin Endocrinol (Oxf); 1982 Jun; 16(6):545-52. PubMed ID: 7105427
[No Abstract] [Full Text] [Related]
9. Effects of propranolol and atenolol on plasma and urinary cyclic adenosine 3',5'-monophosphate in hyperthyroid patients.
Nilsson OR; Andersson RG; Karlberg BE
Acta Endocrinol (Copenh); 1980 May; 94(1):38-45. PubMed ID: 6247872
[No Abstract] [Full Text] [Related]
10. The relationship between thyroid function and the renal response to parathyroid hormone.
Ashby JP; MacPherson JN; Strong JA
Clin Endocrinol (Oxf); 1977 Aug; 7(2):167-70. PubMed ID: 196793
[TBL] [Abstract][Full Text] [Related]
11. Plasma cyclic nucleotide levels in hyperthyroidism.
Lin T
Acta Endocrinol (Copenh); 1979 Jan; 90(1):62-8. PubMed ID: 216209
[TBL] [Abstract][Full Text] [Related]
12. Plasma cyclic adenosine 3',5'-monophosphate (cAMP) levels in hyperthyroid patients.
Velardo A; Baronti D; Pasargiklian E
Exp Clin Endocrinol; 1983 Aug; 82(2):238-41. PubMed ID: 6313403
[TBL] [Abstract][Full Text] [Related]
13. Insulin levels in thyrotoxicosis and primary myxoedema: response to intravenous glucose and glucagon.
Andreani D; Menzinger G; Fallucca F; Aliberti G; Tamburrano G; Cassano C
Diabetologia; 1970 Feb; 6(1):1-7. PubMed ID: 4190847
[No Abstract] [Full Text] [Related]
14. Impaired responsiveness to the effect of glucagon on plasma adenosine 3':5'-cyclic monophosphate in normal man.
Hendy GN; Tomlinson S; O'Riordan JL
Eur J Clin Invest; 1977 Jun; 7(3):155-60. PubMed ID: 196859
[TBL] [Abstract][Full Text] [Related]
15. Cyclic AMP responses to parathyroid hormone and glucagon during lithium treatment.
Waller DG; Albano JD; Millar JG; Polak A
Clin Sci (Lond); 1984 May; 66(5):557-9. PubMed ID: 6323091
[TBL] [Abstract][Full Text] [Related]
16. Dissociation of responsiveness to thyrotropin-releasing hormone and thyroid suppressibility following antithyroid drug therapy of hyperthyroidism.
Martino E; Pinchera A; Capiferri R; Macchia E; Sardano G; Bartalena L; Mazzanti F; Baschieri L
J Clin Endocrinol Metab; 1976 Sep; 43(3):543-9. PubMed ID: 821960
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-induced alterations of plasma levels of cyclic AMP and glucose in patients with liver disease.
Klotz U; Antonin KH
Z Gastroenterol; 1984 Mar; 22(3):147-52. PubMed ID: 6326401
[TBL] [Abstract][Full Text] [Related]
18. Proceedings: Plasma cyclic AMP response to glucagon in thyroid disease.
Elkeles RS; Siddle K; Lazarus JH; Campbell AK; Addison GM
Clin Sci Mol Med; 1974 Sep; 47(3):14P-15P. PubMed ID: 4370892
[No Abstract] [Full Text] [Related]
19. Effect of beta-blocking agents in hyperthyroidism.
Földes J; Bános C; Borvendég J; Gyertyánfy G
Acta Med Acad Sci Hung; 1979; 36(4):375-80. PubMed ID: 45285
[TBL] [Abstract][Full Text] [Related]
20. The influence of hyperthyroidism and hypothyroidism on the beta-adrenergic responsiveness of the turkey erythrocyte.
Bilezikian JP; Loeb JN; Gammon DE
J Clin Invest; 1979 Feb; 63(2):184-92. PubMed ID: 219032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
